Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion

QR Code

Effects of intravitreal bevacizumab on reduced visual acuity and macular thickness secondary to branch retinal vein occlusion

Kadir Eltutar, Fahreddin Acar, Nurhan Dincer, Sibel Zirtiloglu, Erkan Unsal Istanbul Training and Research Hospital, Istanbul, Turkey Background: The purpose of this study was to evaluate the effects of intravitreal bevacizumab injection in the treatment of macular thickness and reduced visual acuit...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Eltutar K, Acar F, Dincer N, Zirtiloglu S, Unsal E
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2013
Sujets:	Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/e4e3fc9a33de42bd8bbf69d9be4d4c90
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Intravitreal bevacizumab in macular edema secondary to branch retinal vein occlusion: 12-month results
par: Thapa R, et autres
Publié: (2012)

The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion
par: Gokce G, et autres
Publié: (2014)

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to retinal vein occlusion
par: Juan Carlos Mesa Guti&eacute;rrez, et autres
Publié: (2008)

Intravitreal bevacizumab for macular edema due to branch retinal vein occlusion: 12-month results
par: Demir M, et autres
Publié: (2011)

VISUAL OUTCOME AFTER INTRAVITREAL BEVACIZUMAB (AVASTIN) IN THE TREATMENT OF BRANCH RETINAL VEIN OCCLUSION
par: Saquib Naeem, et autres
Publié: (2019)

Efficacy and visual prognostic factors of intravitreal bevacizumab as needed for macular edema secondary to central retinal vein occlusion
par: Hirose M, et autres
Publié: (2014)

OCT angiography features associated with macular edema recurrence after intravitreal bevacizumab treatment in branch retinal vein occlusion
par: Kwang-Eon Choi, et autres
Publié: (2019)

Comparison of single injection and three monthly injections of intravitreal bevacizumab for macular edema associated with branch retinal vein occlusion
par: Ito Y, et autres
Publié: (2015)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
par: Ivanovska Adjievska B, et autres
Publié: (2017)

Intravitreal pegaptanib for refractory macular edema secondary to retinal vein occlusion
par: Udaondo P, et autres
Publié: (2011)

Long-term outcomes of intravitreous bevacizumab or tissue plasminogen activator or vitrectomy for macular edema due to branch retinal vein occlusion
par: Kumagai K, et autres
Publié: (2019)

Efficacy of single bevacizumab injection as adjuvant therapy to laser photocoagulation in macular edema secondary to branch retinal vein occlusion
par: Kartasasmita AS, et autres
Publié: (2016)

Grid photocoagulation combined with intravitreal bevacizumab for recurrent macular edema associated with retinal vein occlusion
par: Ogino K, et autres
Publié: (2011)

Comparison between intravitreal bevacizumab and posterior sub-tenon injection of triamcinolone acetonide in macular edema secondary to retinal vein occlusion
par: Tsai MJ, et autres
Publié: (2018)

Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab
par: Yalamanchi S, et autres
Publié: (2011)

Comparing bevacizumab and ranibizumab for initial reduction of central macular thickness in patients with retinal vein occlusions
par: Singer MA, et autres
Publié: (2013)

Relationship between grades of macular perfusion and foveal thickness in branch retinal vein occlusion
par: Sakaguchi H, et autres
Publié: (2012)

Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
par: Dogan E, et autres
Publié: (2018)

The effect of intravitreal bevacizumab on ocular blood flow in diabetic retinopathy and branch retinal vein occlusion as measured by laser speckle flowgraphy
par: Nitta F, et autres
Publié: (2014)

Macular sensitivity and morphology after intravitreal injection of triamcinolone acetonide for macular edema secondary to central retinal vein occlusion
par: Mimura T, et autres
Publié: (2012)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
par: Paulose R, et autres
Publié: (2016)

Critical appraisal of the clinical utility of the dexamethasone intravitreal implant (Ozurdex&reg;) for the treatment of macular edema related to branch retinal vein occlusion or central retinal vein occlusion
par: Chan A, et autres
Publié: (2011)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Presumed bilateral branch retinal vein occlusions secondary to antiepileptic agents
par: Hussain RN, et autres
Publié: (2011)

Cystotomy with or without fibrinogen clot removal for refractory cystoid macular edema secondary to branch retinal vein occlusion
par: Hiroko Yamada, et autres
Publié: (2021)

Effect of initial retinal thickness on outcome of intravitreal bevacizumab therapy for diabetic macular edema
par: Mushtaq B, et autres
Publié: (2014)

Correlation between vascular endothelial growth factor and nonperfused areas in macular edema secondary to branch retinal vein occlusion
par: Fujikawa M, et autres
Publié: (2013)

Outcomes of microincision vitrectomy surgery with internal limiting membrane peeling for macular edema secondary to branch retinal vein occlusion
par: Sato S, et autres
Publié: (2015)

One-year outcome of bevacizumab therapy for chronic macular edema in central and branch retinal vein occlusions in real-world clinical practice in the UK
par: Lip PL, et autres
Publié: (2015)

Relationship between metamorphopsia and inner retinal microstructure following intravitreal ranibizumab injection for branch retinal vein occlusion
par: Yoshimi Sugiura, et autres
Publié: (2021)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2017)

Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema.
par: Bo-Een Hwang, et autres
Publié: (2021)

Influence of ischemia on visual function in patients with branch retinal vein occlusion and macular edema
par: Noma H, et autres
Publié: (2011)

Role of the choroidal vascularity index in branch retinal vein occlusion (BRVO) with macular edema
par: Bo-Een Hwang, et autres
Publié: (2021)

Accelerated ischemic vascular retinopathy after intravitreally injected bevacizumab for central retinal vein occlusion in elderly patients
par: Isola V, et autres
Publié: (2013)

Topographic patterns of retinal edema in eyes with branch retinal vein occlusion and their association with macular edema recurrence
par: Hae Min Park, et autres
Publié: (2021)

Regression of macular edema secondary to branch retinal vein occlusion during anti-TNF-&alpha; therapy for rheumatoid arthritis
par: Shu Kachi, et autres
Publié: (2010)

Grid laser with modified pro re nata injection of bevacizumab and ranibizumab in macular edema due to branch retinal vein occlusion: MARVEL report no 2
par: Narayanan R, et autres
Publié: (2016)

Resolution of vitreomacular traction following intravitreal triamcinolone acetonide injection in an eye with branch retinal vein occlusion
par: Seymenoğlu G, et autres
Publié: (2012)

Role of aflibercept for macular edema following branch retinal vein occlusion: comparison of clinical trials
par: Oellers P, et autres
Publié: (2016)